Senate panel advances drug-pricing legislation

Alia Paavola - Print  | 

The Senate Finance Committee advanced a sweeping bipartisan bill to address prescription drug pricing in the U.S. on July 25, according to STAT news. 

The called "The Prescription Drug Pricing Reduction Act of 2019," was introduced by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore. It addresses drug costs in Medicare Parts B and D, as well as Medicaid. 

The bill passed the committee by a vote of 19-9. The full Senate is expected to vote on the bill in September.

The main components of the bill include a cap on out-of-pocket spending in Medicare Part D and a limit on prescription drug price hikes. In addition, it encourages more price negotiation between insurers and drugmakers. 

More articles on pharmacy:
9 recent drug, device recalls
Owens Healthcare to sell 12 retail pharmacies to CVS
The pharmacies that received the most opioids in every state

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.